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We analyzed the genetics and virulence of 35 strains of TBEV isolated from patients with different forms
of the infection living in the southern Far East region of Russia. The results of moleculargenetics studies
of the TBEV strains showed that most of the strains that cause inapparent infections form a single cluster
(I) with the Oshima 5–10 strain from Japan on the phylogenetic tree. A comparison of the amino acid
sequences of the viral polyproteins of the studied strains identiﬁed 17 amino acid residues distributed
unevenly across the polyprotein that distinctly differed between the clusters of inapparent and virulent
strains. We detected additional substitutions in the NS1 and NS5 proteins. These substitutions might
inﬂuence the pathogenic potential of the strains. Using a model of inbred mice of different ages, we
examined the virulence of these strains and showed the different pathogenic potentials of strains
belonging to different clusters.
& 2013 Elsevier Inc. All rights reserved.Introduction
Tick-borne encephalitis (TBE) in the Russian Far East is of
particular interest to scientists, primarily because it was in this
region that the disease was ﬁrst discovered, its etiology deter-
mined, its epidemiology described, and the basic functioning of its
natural focus was studied (Zilber, 1939). Since its discovery, the
idea has persisted that the classical TBE form of the Far Eastern
subtype is characterized by an extremely severe infection with a
high rate of unfavorable outcomes. As a rule, 67% of all TBE cases
result in severe focal forms of the disease, including those
resulting in fatal outcomes (32%), in patients who have not been
vaccinated against TBE (Leonova, 2009). At the same time, data
from the past two decades show that along with the severe focal
forms of TBE, mild febrile forms of the infection have been
increasingly reported (up to 50% of cases) in the Far East
(Voronok et al., 2009). The clinical manifestations caused by the
TBE virus (TBEV) range from inapparent infections and fevers with
complete recovery of patients to debilitating or fatal encephalitis.
The proportion of fatal human infections varies widely in different
regions and in different years. The factors that determine disease
severity are poorly deﬁned, but correlations between viralll rights reserved.
nova).subtypes and disease severity have been described. TBEV strains
are currently divided into three closely related subtypes, Western-
European (WE), Siberian (SIB) and Far Eastern (FE) (Heinz et al.,
2000). FE TBEV is recognized as the most virulent subtype, with a
20–40% case fatality rate (Leonova, 2009), while the SIB subtype is
considered less virulent (7–8% case fatality rate) (Gritsun et al.,
2003), and the WE strains are the least virulent, with case fatality
rates lower than 2% (Dumpis et al., 1999). However, a range of
clinical manifestations from asymptomatic to encephalitic is
observed for all of the TBEV subtypes (Gritsun et al., 2003), and
the underlying basis of this range has not yet been adequately
explained (Gritsun et al., 2003).
The utilization of molecular genetics methods to study TBEV
has considerably increased the understanding of the structural and
functional characteristics of the causative agent. In 1989, A.G.
Pletnev and co-authors ﬁrst deciphered the complete nucleotide
and amino acid sequences of the TBEV genome (Pletnev et al.,
1990) from the Sofjin strain, which originated in the Far East and
was isolated in 1937 from the brain of a dead patient. Thus far,
only a few TBEV strains have undergone complete genome
sequencing. Most sequencing studies have been performed on
the structure and functions of the E protein, which is the most
important component of the outer surface of the virion envelope
(Rey et al., 1995). The E protein not only determines the tropism of
the virus, but in many respects, it also plays a key role in its
virulence and in the induction of humoral and cellular immunity.
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of the TBEV strains, but their functions are not well studied.
We collected TBEV strains isolated from patients with inappar-
ent and clinical forms of the infection, i.e., those strains with a
known degree of pathogenicity in humans. We aimed to under-
stand why the TBEV population circulating in the southern part of
the Russian Far East in some cases resulted in patients with severe
disease with a fatal outcome, while in other cases, patients had no
clinical signs of infection, regardless of the TBEV strain. We
therefore isolated TBEV strains from patients with different
degrees of clinical symptoms.
The aim of this work was to sequence the complete genomes of
TBEV strains that caused asymptomatic, febrile, and focal forms of
infection in people from the Far East and then characterize the
virulence of these strains.Results
Genome sequence analysis
We identiﬁed the nucleotide sequences for the complete
genomes of 35 TBEV strains. A comparison of the identiﬁed
sequences and construction of phylogenetic trees showed that all
strains, regardless of the disease severity, are related to strains of
the Far Eastern subtype (Fig. 1). In addition, most of the strains
that caused inapparent infections formed a separate cluster, I, in
the phylogenetic tree together with the previously reported
Oshima 5–10 strain from Japan. The remaining strains, which
primarily caused clinical forms of TBE, formed two clusters (II
and III). Cluster II included the prototype strain of the Far Eastern
subtype, the Sofjin strain, and cluster III included the Senzhang
strain from North China. As exceptions, two strains, Primorye-86Fig. 1. Phylogenetic tree based on complete genome sequencing of the Far Eastern TBEV
Oshima-like TBEV strains, cluster II—Soﬁjn-like TBEV strains, and cluster III—Senzhangand Primorye-90, which caused severe focal forms of TBE, were
located in cluster I, and three strains from inapparent forms of TBE,
Primorye-739, Primorye-52, and Primorye-196, were grouped into
clusters II, III and III, respectively. The Shkotovo-94 strain, which
caused a febrile form of TBE, was intermediate between clusters I
and II. The other strains from the febrile form, Kiparis-94,
Primorye-82, and Primorye-94, were grouped into clusters I and
II, respectively.
An analysis of the amino acid sequences of the polyprotein
indicated that the locations of the amino acid substitutions were
largely random, except for 17 positions in the polyprotein that
were different between the inapparent (cluster I) and human
pathogenic (clusters II and III) TBEV strains and conserved within
each group. Table 1 shows the most common amino acid substitu-
tions in the two groups of strains. An analysis of speciﬁc mutations
indicated that most substitutions were synonymous; only 4 of the
17 amino acid substitutions changed the amino acid hydrophobi-
city. These four substitutions most likely have a crucial effect on
the pathogenicity of the strains. Amino acid 111 was observed in a
signal sequence of the core protein and was degenerate in the
pathogenic strains, appearing as Leu, Met, or Val. At the same time,
the inapparent strains lacked this amino acid residue. Residue 111
is located at the C-terminus of the protein in the signal sequence
and allows the host cell signalase to recognize the protein by
cleaving the N-terminus of the prM protein from the polyprotein.
Based on the viral mechanisms of penetration and propagation in
the host cells, the combination of the deletion at position 111 of
the core protein and the replacement of a hydrophilic amino acid
by a hydrophobic amino acid (S45F) in the viral NS3 protease may
be the key substitutions.
Furthermore, we detected a S141G substitution in the NS1
protein, but it is unclear as to whether this substitution could
affect pathogenicity. In the NS5 protein constituting the RNAstrains which caused inapparent, febrile, and severe focal forms of TBE. Cluster I—
-like TBEV strains.
Table 1
Substitutions of amino-acid residues in TBEV proteins characteristic of the strains with different virulence in humans. Single substitutions which do not coincide with the
typical group-speciﬁc substitutions are marked in gray.
Capsid prM E NS1 NS2B NS3 NS4B NS5
32 69 100 111 151 463 141 108 16 45 95 179 213 634 677 692 724
SOFJIN Q K D L A V S F R S M V A S G I A
Primorye-89 . . . . . . . . . . . . . . R . .
Primorye-91 . . . . . . . . . . . . . . . . .
Primorye-92 . . . . . . . . . . . . . . . . .
Spassk-72 . . . . . . . . . . . . . . . . .
Primorye-94 . . . . . . . . . . . A . . . . .
Primorye-87 . . . . . . . . . . . . . . . . .
Dalnegorsk . . . . . . . . . . . . . . . . .
Primorye-739 . . . . . . . . . . . . . . . . .
GLUBINNOE . . . M . . . . . . . . . . . . .
Primorye-196 . . . M . . . . . . . . . . . . .
Primorye-52 . . . M . . . . . . . . . . . .
SENZHANG . . . V . . . . . . . . . . . . .
Kavalerovo . . . V . . . . . . . . . . . . .
Svetlogorie . . . V . . . . . . . . . . . . .
Shkotovo-94 . . . . . . . . K F . . . . . . .
OSHIMA 5-10 R . . V V A . . . F . . . T . V .
Primorye-69 R R . V V A G . K F . . V T K V S
Primorye-437 R R N Del V A G V K F V A V T K V S
Primorye-202 R R N Del V A G V K F V A V T K V S
Primorye-18 R R N Del V A G V K F V A V T K V S
Primorye-895 R R N Del V A G V K F V A V T K V S
Primorye-183 R R N Del V A G V K F V A V T K V S
Primorye-320 R R N Del V A G V K F V A V T K V S
Primorye-208 R R N Del V A G V K F V A V T K V S
Primorye-86 R R N Del V A G V K F V A V T K V S
Primorye-274 R R N Del V A G V K F V A V T K V S
Primorye-750 R R N Del V A G V K F V A V T K V S
Primorye-75 R R N Del V A G V K F V A V T K V S
Primorye-828 R R N Del V A G V K F V A V T K V S
Primorye-823 R R N Del V A G V K F V A V T K V S
Primorye-90 R R N Del V A G V K F V A V T K V S
Primorye-345 R R N Del V A G V K F V A V T K V S
Primorye-270 R R N Del V A G V K F V A V T K V S
Primorye-253 R R N Del V A G V K F V A V T K V S
Primorye-212 R R N Del V A G V K F V A V T K V S
Primorye-332 R R N Del V A G V K F V A V T K V S
Kiparis-94 R R N Del V A G V K F . A V T K V S
Primorye-82 R R N Del V A G V K F V A V T K V S
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which were conserved (S634T, R677K, and I693V) and one of
which (A724S) changed the hydrophobicity of the amino acid
residue.
We also identiﬁed one synonymous amino acid substitution in
each membrane protein of the virus strain groups with different
pathogenicities. Moreover, each substitution is located at a trans-
membrane site. Such substitutions should not affect the conforma-
tion of either the prM or E proteins, and thus, they cannot affect
the pathogenicity of the TBEV strains.Virulence analysis in a mouse model
Subsequently, we focused on studying the virulence properties
of the isolated and sequenced TBEV strains that had caused the
different clinical presentations (focal, febrile, and inapparent) in
humans.
All TBEV strains were isolated following the injection of two-
day-old inbred albino mice. On this basis, we concluded that this
animal model is highly susceptible to the isolation of the strains
causing both inapparent and clinical forms of the infection in
humans. To understand the features of the strains capable of
causing different degrees of pathology in humans, we comprehen-
sively studied their virulence in albino mice of different age groups
as an important biological characteristic.To study the virulence of the TBEV strains, we used albino mice
aged 1.5–2 months (weight 8–10 g) because all of the two-day-old
mice inoculated with TBEV strains from different TBE forms died
on days 5–7 and we failed to identify differences in the develop-
ment of the infection in these mice. We determined the virus titer
of the strains in brain tissue after the intracerebral and subcuta-
neous injection of albino mice. Table 2 shows that after the
intracerebral injection of animals, the virus titer in all groups
was roughly the same and averaged 109.470.33 in Group 1,
109.870.35 in Group 2, and 109.270.23 LD50/ml in Group 3. By
contrast, after the subcutaneous injection, the mean titers were
108.270.45, 108.170.36, and 107.070.25 LD50/ml, respectively. The
invasiveness index averaged 1.1670.28, 1.870.16, and 2.270.22,
respectively, indicating the difference in the neuroinvasive properties
of the strains in these groups. In Groups 1 and 2, the neuroinvasive-
ness index values were typically ≤2.0, indicating high neuroinvasive
activity of these strains. In Group 3, the invasiveness index ranged
from 0.7 to 4.5, suggesting the presence of strain variations with
high, moderate, and low neuroinvasiveness.
We studied the virulence of the strains in the adult albino
mouse model (weight 18–20 g) by intracerebral and subcutaneous
injection with different doses (10 and 1000 LD50) or the same dose
(100 LD50) of the virus (Table 3). When mice were injected
intracerebrally, the strains of all groups showed high virulence.
Following the subcutaneous injection of the virus, Group 1 strains
showed the highest virulence, with an average survival of
Table 2
Characteristics of the Far Eastern TBEV subtype strains that caused different clinical forms of the infection in humans.
№ Strain Passage Region of isolation Year of isolation Virus titer in white mice (lg LD50/ml) Index of invasiveness (I.I.)
i.c. s.c.
Strains caused severe focal form of TBE (group 1)
1 Spassk-72 6 Spassk 1972 8.0 6.3 1.7
2 Dal´negorsk 8 Dalnegorsky 1973 9.8 9.5 0.3
3 Kavalerovo V Kavalerovsky 1985 9.1 8.2 0.9
4 Рrimorye-86 IX Kirovsky 1986 10.0 9.5 0.5
5 Рrimorye-87 V Kavalerovsky 1987 8.0 6.7 1.3
6 Рrimorye-89 VII Arseniev (town) 1987 9.8 7.9 1.9
7 Рrimorye-90 VII Arseniev (town) 1990 10.0 9.7 0.3
8 Рrimorye-92 IV Vladivostok (city) 1992 10.5 8.1 2.4
М7m 9.470.33 8.270.45 1.1670.28
Strains caused febrile form of TBE (group 2)
1 Рrimorye-82 IX Vladivostok (suburbs) 1982 10.1 8.7 1.4
2 Shkotovo-94 V Shkotovo 1994 9.1 7.5 1.6
3 Рrimorye-94 VI Nadezhdinsky 1994 9.5 7.4 2.1
4 Kiparis-94 III Nadezhdinsky,Kiparisovo 1994 10.7 8.7 2.0
М7m 9.870.35 8.170.36 1.870.16
Strains caused inapparent form of TBE (group 3)
1 Primorye-183 IV Nadezhdinsk 1991 9.3 7.5 1.8
2 Primorye-212 II Vladivostok (suburbs) 1991 10.5 6.9 3.6
3 Primorye-253 II Nadezhdinsky, Solovey Kluch 1991 8.3 6.7 1.6
4 Primorye-270 III Nadezhdinsky, Mirny 1991 8.3 6.9 1.4
5 Primorye-332 V Nadezhdinsky 1991 8.5 6.7 1.8
6 Primorye-739 IV within the city of Vladivostok 1992 8.8 6.2 2.6
7 Primorye-18 V Vladivostok (city) 1997 11.0 7.7 3.3
8 Primorye-202 VI Nadezhdinsky, Solovey Kluch 1997 11.0 7.3 3.7
9 Primorye-750 III Nadezhdinsky, Kiparisovo 1998 9.0 6.4 2.6
10 Primorye-828 IV Chernigovka (village) 1998 9.3 7.3 2.0
11 Primorye-52 V Shkotovsky, Anisimovka 1999 9.1 7.9 1.2
12 Primorye-75 II Nadezhdinsk 1999 10.5 7.7 2.8
13 Primorye-274 III Nadezhdinsk 1999 9.2 8.0 1.2
14 Primorye-345 V Vladivostok (suburbs) 1999 9.0 6.7 2.3
15 Primorye-320 II Shkotovo 1999 10.3 8.9 1.4
16 Primorye-437 VIII Area of bay Lazurnaya 1999 7.7 5.5 2.0
17 Primorye-69 VI Ussuriysk 2000 7.7 7.0 0.7
18 Primorye-196 VII Area of bay Lazurnaya 2000 8.2 3.7 4.5
19 Primorye-823 II Krasnoarmeysky 2000 9.5 7.7 1.8
М7m 9.270.23 7.070.25 2.270.22
G.N. Leonova et al. / Virology 443 (2013) 89–989211.271.2 days following an injection of 1000 LD50 and 13.671.7
days following an injection of 100 LD50. Group 2 strains showed
the lowest virulence, with average survival times of 14.072.5 and
22.572.3 days, respectively. In Group 3, strains from the inappar-
ent TBE form were divided into two subgroups, highly invasive
strains with average survival times of 9.670.5 and 14.670.8 days
and minimally invasive strains with average survival times of
17.171.9 and 22.471.6 days, respectively. Fig. 2 shows the
sequential mortality of strains Spassk-72, Shkotovo-94, and Рri-
morye-437, which represent the different (1, 2, 3) groups; the data
demonstrated that Spassk-72 had a higher neurovirulence and
neuroinvasiveness than Shkotovo-94 and Primorye-437. The
results of these experiments indicate that the degree of neuroin-
vasiveness of the TBEV strains is best identiﬁed in adult mice
injected subcutaneously with infectious inocula.
Viral replication and pathogenesis of TBEV in a mouse model
We studied the pathogenesis of TBEV in a mouse model
injected with different TBEV strains: the Spassk-72 strain isolated
from the brain of a dead patient with the severe focal form of TBE,
the Shkotovo-94 strain isolated from the blood of a patient with
the febrile form of TBE, and the Рrimorye-437 (Р-437) strain
isolated from the blood of a patient with the inapparent form of
TBE. As shown in Fig. 2, the virulence of these strains varied with
the intracerebral (10 LD50) and subcutaneous (103.0 LD50) injection
of the animals, i.e., the neuroinvasiveness of these strains wasdifferent. Observation of the dynamics of viral replication in the
organs (Fig. 3A,B,C in the blood, in the spleen, and in the brain
respectively) of albino mice allowed us to obtain additional data
on the virulence of the studied strains. Fig. 3 shows that the
infection developed differently with the same infecting dose
(103 TCID50) for the three strains. TBEV strains that had caused
clinical forms of the disease in humans appeared in the blood of
albino mice on day 3; the highest value was registered for Spassk-72
(104 TCID50). Р-437 appeared in the blood of the experimental
animals on day 5 with a low titer (10 TCID50). The viremic peak for
the strains in cluster II (Spassk-72 and Shkotovo-94) occurred on day
5, while it occurred on day 11 for the strain in cluster I (Р-437). In the
spleen, the viremic peaks for Spassk-72 and Shkotovo-94 also
occurred on day 5, with higher titers compared to the blood. For
Р-437, the peak was again observed on day 11. The viremic peak in the
brain (106 TCID50) for Spassk-72 was observed from days 9–11
(the time of death of the animals). For Shkotovo-94, the maximum
value (4 log TCD50) was observed on day 7. For Р-437, the virus
appeared in the brain of the injected albino mice on day 7 (10 TCID50),
and the virus titer then gradually increased, reaching its maximum
peaks on day 11 (104 TCID50) and day 14 (106 TCID50).
Changes in the weight (Fig. 4А) and body temperature (Fig. 4В)
of the albino mice injected with the same dose (103 TCID50) of the
TBEV strains were used to indicate the severity of the infection.
Fig. 4А shows that Spassk-72, which was isolated from the brain of
a dead patient, caused rapid weight loss in mice followed by death.
Animals injected with Shkotovo-94 began to lose weight rapidly,
Table 3
Survival rate and average life expectancy of mice injected with the regional TBEV strains of the Far Eastern subtype.
No. Strains Survival rate (%) Average life expectancy of mice (days)
i.c. s.c. i.c. s.c. i.c. s.c. i.c. s.c.
10 LD50 1000LD50 100 LD50 100 LD50 10 LD50 1000LD50 100LD50 100LD50
Strains caused severe focal form of TBE (group 1)
1 Spassk-72 0 0 0 0 6.6 11.5 5.6 8.9
2 Dal´negorsk 0 0 0 30 6.4 7.1 5.0 14.7
3 Kavalerovo 0 0 0 10 5.2 8.1 6.5 13.1
4 Рrimorye-86 0 0 30 80 15.3 16.0 14.6 24.9
5 Рrimorye-87 0 30 0 10 6.7 17.3 6.6 14.3
6 Рrimorye-90 0 0 0 0 7.9 10.3 5.8 11.1
7 Рrimorye-91 0 0 0 0 6.7 9.2 5.3 9.3
8 Рrimorye-92 20 0 0 10 10.4 9.8 6.9 12.3
М7m 2.572.5 3.7573.7 3.7573.75 17.579.6 8.1571.2 11.271.2 7.071.1 13.671.7
Strains caused febrile form of TBE (group 2)
1 Рrimorye-82 0 0 0 60 8.7 7.7 8.1 23.6
2 Shkotovo-94 40 40 50 80 18.3 19.6 17.2 24.4
3 Рrimorye-94 80 40 60 90 25.2 16.0 22.3 26.3
4 Kiparis-94 0 30 0 10 7.0 12.8 6.4 15.7
М7m 30719.1 27.577.5 27.5716.0 60717.8 14.874.2 14.072.5 13.573.8 22.572.3
Strains caused inapparent form of TBE (group 3)
А. Highly invasivness
1 Primorye-183 0 10 0 10 6.5 10.9 6.4 12.2
2 Primorye-332 0 10 0 20 7.7 11.1 5.9 13.3
3 Primorye-739 0 0 0 10 5.4 7.7 6.6 12.4
4 Primorye-52 0 0 0 30 7.2 9.1 7.3 16.0
5 Primorye-75 10 0 10 10 11.1 9.4 10.3 13.4
6 Primorye-274 0 0 0 20 5.8 9.1 8.6 14.4
7 Primorye-320 0 0 0 10 10.3 11.8 7.0 13.3
8 Primorye-202 0 0 0 40 7.6 8.4 7.0 18.7
9 Primorye-828 0 0 0 40 7.0 8.6 7.0 17.7
М7m 1.1171.1 2.270.5 1.1171.1 21.174.2 7.670.6 9.670.5 7.370.4 14.670.8
В. Low invasivness
1 Primorye-270 40 90 0 100 17.0 26.2 8.3 28.0
2 Primorye-18 0 10 10 90 15.9 16.5 10.5 26.3
3 Primorye-345 70 0 10 40 21.3 11.9 10.0 18.5
4 Primorye-437 70 60 0 60 22.4 25.1 8.0 22.1
5 Primorye-69 0 0 50 100 6.4 13.6 19.2 28.0
6 Primorye-196 10 60 0 90 8.1 21.1 4.6 26.2
7 Primorye-823 20 0 0 40 10.1 8.9 6.7 17.1
8 Primorye-212 0 10 0 30 6.5 16.3 6.4 18.0
9 Primorye-253 0 20 0 30 8.4 14.6 6.1 17.6
М7m 23.379.9 27.8711.1 7.875.4 64.4710.1 12.972.1 17.171.9 8.971.4 22.471.6
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end of the experiment. Animals injected with the P-437 strain
(isolated from an inapparent infection) gained weight through day
8 and then gradually began to lose weight.
Discussion
The long-standing notion that the Far Eastern subtype TBEV strains
cause only severe forms of TBE is gradually dissipating. Over the past
20 years, we have conducted research aimed at isolating and
characterizing TBEVs causing clinical courses of varying severity, from
inapparent to severe focal forms of TBE (Leonova et al., 2007). We have
shown that the Far Eastern viruses have heterogeneous virulence in
humans; the bulk of these infections (as high as 70%) are caused by
non-neuroinvasive strains, which are rapidly and completely elimi-
nated from the human body following the tick bite. Additionally,
neuroinvasive strains causing lethal infections in albino mice comprise
a relatively small proportion of the virus population (as much as 30%).
In this study, we obtained the molecular structure and deter-
mined the degree of virulence of these TBEV strains, allowing us to
identify characteristics related to the pathogenic potential of the
strains of the Far Eastern TBEV subtype, which are capable of
causing both inapparent and clinical forms of TBE.The molecular genetics analyses of 35 TBEV strains causing
different levels of disease severity demonstrated that the bulk of
the strains that cause inapparent infections formed a separate
cluster (I) in the phylogenetic tree near the previously reported
Oshima 5–10 strain from Japan (Takashima et al., 1997). Two other
clusters with the prototype strains Sofjin (II), which was isolated in
1937 in the Russian Far East, and Senzhang (III), which was
isolated in 1953 in China, primarily include human pathogenic
strains capable of causing clinical forms of the disease.
Recent studies on the biology of viruses have considered
virulence to be a phenotype of the polygenic inheritance of
pathogenicity (Heinz, 2003). Hence, if pathogenicity is a constant
species characteristic, then virulence is its individual strain vari-
able (McMinn, 1997). In current studies included not only obtain-
ing the complete genomic characteristics of the TBEV strains but
also determining their virulence to identify correlations between
these major characteristics and their inﬂuence on the course of
infection in patients with TBE.
We have primarily shown that the studied TBEV strains were
different in some of their biological properties (neurovirulence and
neuroinvasiveness). They had rather high pathogenic potential in
albino mice when injected intracerebrally, particularly in two-day-
old animals and animals weighing 8–10 and 18–20 g. Therefore,
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Fig. 2. Survival rate of mice injected with the strain Spassk-72 (caused severe focal form of TBE; related to the cluster II), Shkotovo-94 (caused febrile form of TBE; related to
the cluster II), and Primorye-437 (caused inapparent form of TBE; related to the cluster III) А—intracerebral injection (10 LD50); В—subcutaneous injection (1000 LD50).
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differences between the studied strains. In the group containing
strains causing inapparent infection, the pathogenic potential was
signiﬁcantly lower compared to the strains causing severe focal TBE.
In recent years, studies have attempted to identify the mole-
cular mechanisms of viral neurovirulence and neuroinvasiveness
(Karganova, 2009; Goto et al., 2002; Gritsun et al., 2003; Gritsun
et al., 2003; Hayasaka et al., 1999; Hayasaka et al., 2001; Tamura
et al., 2007). In fact, the speciﬁc TBEV clones studied by these
authors have furthered the understanding of the basics of viru-
lence in strains of the virus capable of causing different courses of
infection.
There are three possible mechanisms to explain the brain tissue
damage caused by the viruses. First, the virus may cause direct
damage to neurons. Second, virus-induced inﬂammatory
responses may result in neuronal death. Finally, a combination of
both of these mechanisms may be the cause of severe infection
(King et al., 2007).
Recently, D. Ruzek and co-authors (Ruzek et al., 2009; Ruzek
et al., 2011) reported interesting data on the immunopathology of
TBE and the breakdown of the blood-brain barrier (BBB) in
experimentally injected non-inbred mice with different immuno-
deﬁciencies. The authors identiﬁed two damaging factors in
normal mice with fully developed immune systems: the direct
destructive effect of the virus on the cells of the central nervous
system (CNS) and the immunopathological response. These factors
inﬂuence the clinical outcome of the disease in humans and
animals (Ruzek et al., 2009). Changes to the BBB are acharacteristic feature of many CNS infections and are most likely
essential for disease progression (Olsen et al., 2007). Considering
the above results on TBEV accumulation in a laboratory model of
albino mice (Fig. 3), we suggest that animals injected with the
Spassk-72, Shkotovo-94, and P-437 strains had different courses of
infection. Thus, in albino mice, we detected initial reactive changes
in the BBB structures within one day of injection with the highly
virulent Spassk-72 strain (the meninges and vascular plexus), and
on days 5–7, we observed destructive changes in the indicator
areas of the brain (the subcortical and stem structures and the
cerebellum) (Somova et al., 2013). Based on the literature (Ruzek
et al., 2011; Tigabu et al., 2009), in this case, we believe that the
BBB broke down in mice injected with the Spassk-72 strain even at
early stages of the infection. This breakdown was followed by an
abrupt decrease in body weight and an increase in the virus titer in
the brain accompanied by destructive changes in the cells.
Although the infecting dose was low (3 log TCID50), an acute
clinical picture developed, resulting in fatal outcomes in all
animals. This most likely indicates the combined mechanism of a
severe course of the infection associated with the direct destruc-
tion of neurons and virus-induced inﬂammatory responses.
In contrast, the Р-437 strain, which had caused an inapparent
form of infection in humans, had a prolonged period of virus
accumulation in the brains of experimentally injected albino mice
(7–14 days), which showed only an insigniﬁcant reaction by the
pial vessels. The individual mutations identiﬁed in the active
center of the viral serine protease (NS2B/NS3 complex) most likely
contributed to the delay of virus accumulation at the site of
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Fig. 3. Dynamics of the virus multiplication in the organs (brain, spleen, and blood)
of albino mice injected with different TBEV strains: А—Spassk-72 caused focal form
of TBE; В—Shkotovo-94: febrile form of TBE; С—Primorye-437: inapparent form of
TBE. The horizontal axis shows the virus titer in log TCD50; the vertical axis—
observation days after injection.
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authors (Ruzek et al., 2009, 2011) have also discussed this type of
damage. In later stages in mice injected with the Р-437 strain, we
observed widespread severe changes in neurons of a lytic type
(Somova et al., 2013). Additionally, on day 8 post-injection, the
animals began to lose weight, but they only began to show stable
weight loss on day 14. The body temperature of the animals
decreased gradually. The P-437 strain can possibly be character-
ized by the direct penetration of the virus into the brain without
BBB breakdown. This was experimentally conﬁrmed (Ruzek et al.,
2011) when a low-virulence TBEV strain showed prolonged
replication in the mouse. Consequently, the characteristic features
of TBEV strains causing inapparent forms of TBE were a long-term
accumulation of the virus in injected albino mice, a weak reaction
of the BBB cells, and destruction of neurons in the later stage of
observation.
The Shkotovo-94 strain was located in the phylogenetic tree
between clusters I and II and shared 15 of 17 amino acid residues
that are characteristic of the virus strains causing focal disease.
Two amino acid substitutions (16Lys and 45Phe in NS3) were also
characteristic of Shkotovo-94 and other inapparent virus strains.The substitutions are located in the viral protease that is part of
the NS2B/NS3 protein complex. This substitution likely reduces the
pathogenic potential of strains such as Shkotovo-94.
Unlike Shkotovo-94, the Primorye-82 and Kiparis-94 strains,
which also cause a febrile form of the disease, do not form
separate branches in the phylogenetic tree and are located in the
strain group of cluster I according to the speciﬁc amino acid
substitutions. They have a unique substitution of one amino acid
residue, D809N, in the NS5 protein (data not shown). It is possible
that such a substitution can increase the pathogenic properties of
these strains; however, at present, its mechanism is unknown.
We found that the Primorye-94 strain, which causes a febrile
form of TBE and localizes with the pathogenic strains of cluster II
in the phylogenetic tree, contained a number of amino acid
substitutions that are atypical for the groups of inapparent and
pathogenic strains, including V141I in the E protein, K47R in the
NS1 protein, A68V, L143I and T184I in the NS3 protein, V179A in
the NS4B protein, and E878G in the NS5 protein. It can be assumed
that such a combination of many amino acid substitutions may
reduce the pathogenicity of the strain.
The comparison of the amino acid sequences of the viral
polyproteins of the studied strains allowed the identiﬁcation of
17 amino acid residues distributed unevenly across the polypro-
tein that differ between clusters of inapparent and virulent strains.
The presence of 17 substitutions in the polyprotein is not evidence
that all 17 substitutions affect the virulence of the strains. Some of
these substitutions may reﬂect the evolutionary history of the
virus and be neutral or irrelevant to the strain pathogenicity.
Furthermore, some substitutions do not change the properties of
the amino acid residues; therefore, they do not affect the protein
conformation and thus do not affect strain pathogenicity. How-
ever, it is also possible that a combination of several irrelevant
substitutions can change the conformation of the proteins and
affect the pathogenicity of the strains.
The analysis indicates that a combination of the unique dele-
tion of amino acid 111 in core protein C with the conserved
substitution R16K and the signiﬁcant substitution S45F, which
changes the hydrophobicity of the amino acid residue in the NS3
protein (i.e., in the viral protease), are the most likely substitutions
affecting strain pathogenicity. The amino acid deletion in the
signal sequence of the core protein reduces the possibility of (or
decelerates) the cleavage of the N-terminus of the premembrane
protein. Moreover, according to the methods of homology model-
ing and molecular dynamics, the two substitutions in the protease,
or rather in the NS2B/NS3 complex, change the conformation of
the protease complex, thus decreasing its ability to bind to the
substrate (Potapova et al., 2011). Mammalian cells are known
(Monastyrskaya et al., 2004) to contain a DExH-like RNA helicase
that displays signiﬁcantly increased expression with TBEV replica-
tion. We demonstrated that substitutions in the NS2B/NS3 com-
plex affected the replication rate of the studied strains (Table 1 and
Fig. 3). A comparison of the complete nucleotide sequences of
another ﬂavivirus, the neurovirulent strain of the Japanese ence-
phalitis virus, with the three attenuated variants identiﬁed muta-
tions at highly conserved sites of the proteins NS2B (E63D) and
NS3 (A105G) (Wallner et al., 1996).
Another signiﬁcant amino acid substitution, which may
change the hydrophobicity and conformation of the protein,
is the S141G substitution in the NS1 protein; however, the
exact role of the NS1 protein in the pathogenicity of the virus is
currently unknown. In the RNA polymerase domain of the NS5
protein of inapparent strains, we found four substitutions, of
which three were conserved (S634T, R677K, and I692V) and
one (A724S) changed the hydrophobicity of the amino acid
residue. The combination of these substitutions can affect the
pathogenic potential of the strains. Determining the role of
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studies on the directed introduction of speciﬁc mutations and
the assessment of their impact using reverse genetics.
Comprehensive experimental research aimed at studying the
molecular characteristics and virulence of the TBEV population
has shown that all TBEV strains isolated from patients, regard-
less of the documented form of the infection, exhibit patho-
genicity in humans. However, the pathogenic potential
(virulence) of the strains isolated from patients with inapparent
and clinical forms of TBE differs signiﬁcantly. In the blood, each
TBEV strain displays genetic characteristics that can inﬂuence
the occurrence of relatively favorable or dramatic events in
the host.
In this report, we did not discuss the role of the mammalian
immune system, which has a great inﬂuence on the fate of the
causative disease agent. When inapparent TBEV strains enter the
blood after a tick bite, the chances of their survival in the host are low,
and as mentioned above (Leonova et al., 2007), these strains represent
the bulk of the virus population. As a rule, even at the initial stage of
the infection, these strains are eliminated from the host.
The strains that cause clinical forms of the infection may have a
different effect in the host, which depends not only on the
molecular characteristics of the causative agent but also on the
state of the immune system. The latter is also known to determine
different courses of infection, contributing to either the elimina-
tion of the virus followed by patient recovery or to an unfavorable
outcome.
There are new opportunities for predicting the course and
outcome of TBE that consider the molecular characteristics of the
causative agent and the state of the host immune system at theinitial stage of the infection. These opportunities should be
considered when developing preventive and medical preparations.Materials and methods
Virus strains
We examined 35 TBEV strains isolated in the southern part of
the Russian Far East from patients with different forms of TBE. The
strains were isolated from 2-day-old albino mice following intra-
cerebral injection. The clinical manifestations of the infection were
observed over two to three weeks. The focal strains were isolated
from the brains of patients who died from TBE. The febrile strains
were isolated from the blood of those patients with this form of
TBE infection diagnosed in hospital infectious departments. Inap-
parent strains were isolated from the blood of patients on days 1–5
after sucking of antigen-positive ticks by ELISA. Since these
patients had no clinical symptoms, they did not consult the doctor.
Virulence analysis
We studied the neurovirulence and neuroinvasiveness of 31 Far
Eastern subtype TBEV strains causing severe focal (Group 1, n¼8),
febrile (Group 2, n¼4), and inapparent (Group 3, n¼19) forms of
the infection (Table 1). We used the strains obtained from 3 to
9 passages in two-day-old inbred mice. Viral titers of the TBEV
strains were determined through the intracerebral and subcuta-
neous injection of albino mice weighing 8–10 g. These indicators
were calculated for 1 mL. The invasiveness index was calculated as
G.N. Leonova et al. / Virology 443 (2013) 89–98 97the difference in the values of the infectious titers between
hypodermic and intracerebral injections.
We performed a comparative study of the neurovirulence of
these strains by injecting mice weighing 18–20 g with different
doses of TBEV. The viral dose (log LD50) was determined by
titration of the strain in white mice using the intracerebral method
of infection outlined by Hayasaka et al. (1999); mice were injected
intracerebrally with 10 LD50 per 0.03 mL and subcutaneously with
1000 LD50 per 0.2 mL. In other experiments, mice were injected
intracerebrally (0.03 mL) and subcutaneously (0.2 mL) with a dose
of 100 LD50 of the virus. For each experiment, we used 10 mice,
and the observation period was 28 days. The survival rate and
average life expectancy of the animals served as the evaluation
criteria of neurovirulence.
We studied the dynamics of the accumulation of different TBEV
strains in the organs of albino mice (blood, spleen, and brain). We
used the same injection dose (103 TCID50) for the three strains
(Spassk-72, Shkotovo-94, and Primorye-437). To determine the viral
titer, continuous pig embryo kidney cells (PK cells) cultivated in
medium 199 containing 7% fetal calf serum and gentamicin were
used. From the brain and spleen of the experimental animals, we
took 0.1 g pieces and triturated them in 1 mL mortar. We obtained
10% suspension which was centrifuged at 3–4 thousands rpm for
15 min and followed by 10-fold dilution. Overnight monolayers of
PK cells grown in 24-well plates were infected with 10-fold dilutions
of the experimental samples. After 1 h of contact at 37 1C, the
infected cell monolayer was washed with medium 199. 199 main-
tenance medium containing gentamicin and 1% fetal calf serumwas
then added, and the plates were placed in an incubator. Observa-
tions of cytopathic effects (CPEs) were made for 5–7 days. The
samples were simultaneously titrated in PK cell cultures using
indicators of the virus titer by CPEs as described above.
Changes in the weight of the animals injected with the
different strains were observed over four weeks, and changes in
body temperature were observed for 15 days. Animals were kept
in a vivarium according to the USSR Ministry of Public Health
Regulation No. 1189 of 10.10.1983. Experiments were performed
according to the USSR Ministry of Public Health Regulations No.
755 of 12.09.1977 and No. 701 of 27.07.1978 for the humane
treatment of animals.
Genetic analysis
We determined the complete genome sequences of 35 TBEV
strains isolated in the southern region of the Russian Far East from
patients with different forms of TBE. Total RNA extraction was
performed using the RIBO-zol-A kit (AmpliSens, Russia) according
to the manufacturer's protocol. Reverse transcription and ampliﬁ-
cation of the viral RNAs were performed using a constructed set of
39 primers selected by comparison of the complete genome
sequences of the TBEV strains from the GenBank database
(U27495, AF069066, U39292, AB062063, AY182009, DQ862460,
AB062064, and DQ989336). The reverse transcription reaction was
performed using the Reverta-L-100 kit (AmpliSens, Russia) accord-
ing to the manufacturer's protocol. The virus genome was
sequenced using either a CEQ 8800 (Beckman Colter) or Prism
3100 (Applied Biosystems) Genetic Analyzer according to the
manufacturer's protocol.
To obtain complete genome sequences of the TBEV strains,
overlapping nucleotide sequences for of all of the genome frag-
ments for each strain were aligned and pooled using the program
BioEdit (http://www.mbio.ncsu.edu/BioEdit/). The nucleotide
sequences were translated into amino acid sequences online at
http://web.expasy.org/translate/ (Bioinformatics Resource Portal).
All nucleotide and translated amino acid sequences of the
strains were deposited in the international GenBank database(http://www.ncbi.nlm.nih.gov/) under the following accession
numbers: FJ402886—Dalnegorsk, FJ402885—Kavalerovo,
JQ825146—Kiparis-94, GQ228395—Primorye-18, JQ825154—Pri-
morye-52, EU816453—Primorye-69, JQ825152—Primorye-75,
JQ825148—Primorye-82, EU816455—Primorye-86, JQ825149—
Primorye-87, FJ906622—Primirye-89, FJ997899—Primorye-90,
JQ825150—Primorye-91, HQ201303—Primorye-92, EU816454—
Primorye-94, JQ825153—Primorye-183, JQ825155—Primorye-196,
JQ825157—Primorye-202, JQ825158—Promorye-208, EU816450—
Primorye-212, EU816451—Primorye-253, EU816452—Primorye-
270, JQ825159—Primorye-274, JQ825160—Primorye-320,
AY169390—Primorye-332, JQ825161—Primorye-345, JQ825162—
Primorye-437, JQ825156—Primorye-739, JQ825163—Primorye-
750, JQ825164—Primorye-823, JQ825144—Primorye-828,
JQ825145—Primorye-895, JQ825147—Shkotovo-94, JQ825151—
Spassk-72, and GU121642—Svetlogorie. The sequences
EU816450, EU816451, EU816452 and AY169390 were published
previously (Belikov et al., 2010).
The nucleotide and amino acid sequences were compared
online at mafft.cbrc.jp/alignment/server/ using the program
MAFFT version 7. The phylogenetic analysis of the nucleotide
sequences of the analyzed complete genomes of the virus strains
and the previously reported genome sequences of the Far Eastern
subtype TBEV strains (Sofjin—AB062064, Oshima 5–10—
AB062063, Glubinnoe—DQ862460, and Senzhang—AY182009)
was performed by neighbor joining according to the evolutionary
model proposed by Tamura and Nei using the TreeConW software
package (Tigabu et al., 2009). The reliability of the reconstructed
tree topology was assessed by bootstrapping based on 1000
pseudoreplicates.Acknowledgments
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